The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes ...

A new discovery points the way toward an effective HCV vaccine. A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at ...

Scientists have published a ground-breaking study of the structure and function of a central protein in the liver: NTCP, a cellular-entry pathway for bile salts, but also for certain hepatitis viruses ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

The nonstructural 5B (NS5B) protein is the catalytic core of the hepatitis C virus replication machinery. The RNA-dependent RNA polymerase activity of NS5B supports a staggering rate of viral ...

In a recent study published in Scientific Reports, researchers identified serological Hepatitis C virus (HCV) signatures and human immunodeficiency virus (HIV) signatures through the secondary ...

Individuals living with both HIV and hepatitis C virus (HCV) who ultimately developed hepatocellular carcinoma (HCC) showed greater suppression of plasma extracellular vesicles (pEVs) after HCV ...

Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...

The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes ...

Lisa Eshun-Wilson receives funding from the National Science Foundation. Alba Torrents de la Peña receives funding from Netherlands Organization for Scientific Research (NWO) Rubicon Grant 45219118.